HeartFlow CEO Offloads More Than 22,000 Shares

A recent regulatory filing has revealed a significant transaction by the top executive of HeartFlow, Inc.. Chief Executive Officer John C.M. Farquhar sold 22,562 shares of the company’s common stock on July 10, 2026. The sale was conducted at a weighted average price of $27.75 per share, according to the SEC Form 4.

HeartFlow operates in the healthcare technology sector, specifically focusing on health information services. The company provides non-invasive solutions designed to assist in the diagnosis and management of coronary artery disease. Its flagship offering, the HeartFlow Platform, utilizes artificial intelligence and computational fluid dynamics. This technology processes standard computed tomography angiography scans to generate personalized, three-dimensional digital models of a patient’s coronary arteries.

Following the transaction, market activity for the stock has shown stability. As of the latest market snapshot, HeartFlow’s stock price is trading at approximately $25.49, reflecting a change of 0.0% from the previous close. The company currently holds a market capitalization of roughly $2.19 billion. The trading price on the date of the CEO’s sale was notably higher than the current valuation levels.

What to watch

• Future SEC filings: Monitor subsequent Form 4 filings to track any further changes in executive ownership.
• Clinical adoption rates: Look for data regarding the integration of the HeartFlow Platform into new medical facilities.
• Quarterly earnings: Watch for upcoming financial reports that detail revenue growth and operating margins.

Source: original release